MARSHALL WACE, LLP - MARKER THERAPEUTICS INC ownership

MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 76 filers reported holding MARKER THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of MARKER THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$117,000
-59.5%
123,478
-27.7%
0.00%
-100.0%
Q3 2021$289,000
-68.4%
170,712
-47.9%
0.00%
-75.0%
Q2 2021$915,000
+127.0%
327,826
+134.5%
0.00%
+33.3%
Q4 2019$403,000
-51.2%
139,787
-13.4%
0.00%
-50.0%
Q3 2019$825,000161,4000.01%
Other shareholders
MARKER THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 3,142,857$2,986,0001.05%
ACT CAPITAL MANAGEMENT, LLC 354,400$337,0000.24%
NEA Management Company, LLC 10,714,285$10,179,0000.21%
Long Focus Capital Management, LLC 1,233,257$1,172,0000.16%
Mandatum Life Insurance Co Ltd 99,000$94,0000.02%
MATRIX ASSET ADVISORS INC/NY 150,000$143,0000.02%
AR ASSET MANAGEMENT INC 71,500$68,0000.02%
KENNEDY CAPITAL MANAGEMENT LLC 590,118$561,0000.01%
WealthTrust Axiom LLC 22,700$21,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 324,216$308,0000.01%
View complete list of MARKER THERAPEUTICS INC shareholders